Table 1. Patient characteristics of all referred and hospitalized patients at the University Hospital Basel during the two study periods 2004/05 and 2014/15.
| 2004/05 | 2014/15 | p-value | |||||||
|---|---|---|---|---|---|---|---|---|---|
| All patients n = 195 |
Hospitalized patients n = 45 (23.1%) |
All patients n = 516 |
Hospitalized patients n = 81 (15.7%) |
||||||
| Demographic characteristics (n, % or median, IQR) | |||||||||
| Male | 137 | 70.3% | 31 | 68.9% | 298 | 57.8% | 53 | 65.4% | 0.003* |
| Female | 58 | 29.7% | 14 | 31.1% | 218 | 42.2% | 28 | 34.6% | |
| Age in years | 26.9 | 22.9–36.9 | 26.8 | 20.6–35.5 | 26.2 | 20.7–35.5 | 26.5 | 20.9–35.8 | 0.34* |
| Region of origin (n, %) | |||||||||
| EUR | 66 | 33.8% | 25 | 55.6% | 60 | 11.6% | 13 | 16.0% | <0.0001* |
| EMR | 25 | 12.8% | 7 | 15.6% | 78 | 15.1% | 12 | 14.8% | 0.439* |
| SEAR | 3 | 1.5% | 0 | 0.0% | 22 | 4.3% | 4 | 4.9% | 0.078* |
| WPR | 4 | 2.1% | 2 | 4.4% | 7 | 1.4% | 3 | 3.7% | 0.736* |
| AFR | 8 | 4.1% | 2 | 4.4% | 169 | 32.8% | 44 | 54.3% | <0.0001* |
| AMR | 0 | 0.0% | 0 | 0.0% | 8 | 1.6% | 3 | 3.7% | |
| Unknown | 89 | 45.6% | 9 | 20.0% | 172 | 33.3% | 2 | 2.5% | 0.003* |
| Reasons for referral (n, %) | |||||||||
| Infectious disease | 44 | 22.6% | 15 | 33.3% | 189 | 36.6% | 45 | 55.6% | <0.001* |
| Non-infectious disease | 151 | 77.4% | 30 | 66.7% | 327 | 63.4% | 36 | 44.4% | |
| Reasons for hospital admissions (n, %) | |||||||||
| Infectious diseases | 15 | 33.3% | 45 | 55.6% | 0.02 | ||||
| Internal medicine | 5 | 11.1% | 15 | 18.5% | 0.23 | ||||
| Gynaecology and obstetrics | 11 | 24.4% | 7 | 8.6% | 0.02 | ||||
| Neurology | 2 | 4.4% | 7 | 8.6% | 0.49 | ||||
| Surgery | 7 | 15.6% | 3 | 3.7% | 0.03 | ||||
| Psychiatrics | 4 | 8.9% | 2 | 2.5% | 0.19 | ||||
| Oncology | 1 | 2.2% | 2 | 2.5% | 1.00 | ||||
| Duration of hospitalization in days (median, IQR) | |||||||||
| All hospitalized patients | 6 | 5–11 | 5 | 4–10 | 0.28 | ||||
| Patients with infectious diseases | 7 | 5–20 | 7 | 4–10 | 0.41 | ||||
| Patients with non- infectious diseases | 6 | 4–9 | 4.5 | 2–6 | 0.14 | ||||
| Isolation (n, % or median, IQR) | |||||||||
| Patients isolated | 13 | 28.9% | 24 | 29.6% | 0.920 | ||||
| Duration of isolation in days | 9.5 | 5–21 | 6 | 3–10 | 0.21 | ||||
AFR: African Region; AMR: Region of the Americas; EMR: Eastern Mediterranean Region; EUR: European Region; SEAR: South-East Asia Region; WPR: Western Pacific Region; IQR: interquartile range
* p-values refer to comparisons of variables from all patients between the two study periods